The SPAC said it will target Silicon Valley-based technology companies with applications in the energy or industrial sectors. It plans to list on the Nasdaq under RSVAU. Read more.
Related Posts
Genesis Unicorn Capital Cuts Deal Size 25% Ahead of $75M IPO
The new SPAC intends to target the biotechnology and pharmaceutical sectors, specifically middle market and emerging growth businesses operating with a total enterprise value from $200 million to $1 billion.
Replay Acquisition Shareholders Approve Merger With Finance of America for $538M
Estimated cash proceeds will consist of a $250 million PIPE in addition to Replay Acquisition’s $288 million of cash in trust, subject to any redemptions.
Forbion European Acquisition Files Investor Presentation on enGene Deal
The target is advancing its immune-oncology platform, which includes its clinical-stage lead candidate detalimogene voraplasmid (EG-70), a non-viral gene therapy.
Blue World Acquisition’s Merger Partner Taking Over Extension Payments
Fuji Solar has agreed to provide additional support to the parties' merger agreement with Vietnam Sunergy Cell Company Limited (dba TOYO).